QuEChERS analytical approach for monitoring endocrine-disrupting chemicals in human urine

QuEChERS分析方法用于监测人尿液中的内分泌干扰化学物质

阅读:1

Abstract

This study introduces an analytical method for the determination of endocrine-disrupting chemicals (EDCs) in human urine samples, employing QuEChERS as a clean-up step for the first time in this biological matrix. Sample preparation was rigorously optimized through the evaluation of sample and final dilution volumes, balancing the need to reduce matrix interference without sacrificing sensitivity. High-performance liquid chromatography coupled with a triple quadrupole-time-of-flight mass spectrometer (HPLC-QTOF) was employed, enabling the detection of 13 target analytes (five OPEs, five phthalates, and three parabens' metabolites). Chromatographic separation was achieved in 16 min, and mass spectrometry parameters were fine-tuned to maximize signal sensitivity. The method was validated by assessing parameters such as selectivity, linearity, precision, accuracy, and sensitivity. Linearity of response was demonstrated for all of the compounds (r(2) > 0.99), with method detection limits of 0.01-0.33 ng/mL and limits of quantification of 0.03-1.08 ng/mL. Accuracy ranged from 67 to 99% and inter- and intra-day precision were under 20%, for the majority of the analytes. The validated method was then applied to 39 human urine samples, confirming its reliability and practical utility for monitoring EDC exposure in urban populations. The highest concentrations were found in parabens, followed by phthalates and finally OPEs, with median values of 117, 43.5, and 25.4 ng/g of creatinine, respectively. The detection of all three EDC groups in 100% of the samples underscores the importance of this comprehensive analytical approach being capable of simultaneously assessing these contaminants in human biomonitoring studies.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。